AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 10791526 — intervention group
Group type: COMPARATOR
Intervention: Standard treatment schedule (26-day regimen of melarsoprol with doses increasing from 1.2 to 3.6 mg/kg)
Number of subjects: 500
Study 9289940 — intervention group
Group type: EXPERIMENTAL
Intervention: Tensiomin (50 mg)
Number of subjects: 49
Study 9289940 — intervention group
Group type: EXPERIMENTAL
Intervention: Tensiomin (100 mg)
Number of subjects: 49
Study 9289940 — intervention group
Group type: COMPARATOR
Intervention: Capoten (50 mg)
Number of subjects: 49
Study 9289940 — intervention group
Group type: COMPARATOR
Intervention: Capoten (100 mg)
Number of subjects: 49
Study 9289940 — intervention group
Group type: COMPARATOR
Intervention: Lopirin (50 mg)
Number of subjects: 49
Study 8240197 — intervention group
Group type: EXPERIMENTAL
Intervention: Pressurization to 200 mBar for 3 h
Number of subjects: 51
Study 8240197 — intervention group
Group type: COMPARATOR
Intervention: Rest (Control)
Number of subjects: 51
Study 3602016 — intervention group
Group type: EXPERIMENTAL
Intervention: Twice daily regimen of combined inhalation of salbutamol and beclomethasone dipropionate from a single inhaler
Number of subjects: 20
Study 3602016 — intervention group
Group type: EXPERIMENTAL
Intervention: 4-times daily regimen of combined inhalation of salbutamol and beclomethasone dipropionate from a single inhaler
Number of subjects: 20
Study 3602016 — intervention group
Group type: COMPARATOR
Intervention: Separate inhalers for salbutamol and beclomethasone dipropionate
Number of subjects: 20
Study 30514741 — intervention group
Group type: EXPERIMENTAL
Intervention: Hill's Prescription Diet k/d Feline with chicken, dry
Number of subjects: 28
Study 30514741 — intervention group
Group type: COMPARATOR
Intervention: Royal Canin Renal Support A Feline, dry
Number of subjects: 28
Study 27645692 — intervention group
Group type: EXPERIMENTAL
Intervention: Metabolic tumor volume (MTV) pre-treatment >32 mL
Number of subjects: 230
Study 27645692 — intervention group
Group type: EXPERIMENTAL
Intervention: Higher tMTV-pre (per 10-mL increase)
Number of subjects: 230
Study 27645692 — intervention group
Group type: EXPERIMENTAL
Intervention: Radiotherapy dose (≤60 Gy vs. 61-69 Gy or ≥70 Gy) in patients with tMTV-pre >32 mL
Number of subjects: 230
Study 27645692 — intervention group
Group type: EXPERIMENTAL
Intervention: Radiotherapy dose in patients with tMTV-pre ≤32 mL
Number of subjects: 230
Study 25190222 — intervention group
Group type: EXPERIMENTAL
Intervention: POST intervention (4 sessions pre-release and 2 sessions post-release focusing on HIV prevention and access to care)
Number of subjects: 0
Study 25190222 — intervention group
Group type: COMPARATOR
Intervention: Standard of care (control group)
Number of subjects: 0
Study 23417103 — intervention group
Group type: EXPERIMENTAL
Intervention: Partially paralyzed hands (PPH)
Number of subjects: 24
Study 23417103 — intervention group
Group type: EXPERIMENTAL
Intervention: Completely paralyzed hands (CPH)
Number of subjects: 24
Study 23417103 — intervention group
Group type: EXPERIMENTAL
Intervention: All stroke patients
Number of subjects: 24
Study 21654533 — intervention group
Group type: EXPERIMENTAL
Intervention: PAP stimulus (1 set of 3 repetitions at 87% 1RM)
Number of subjects: 9
Study 21654533 — intervention group
Group type: COMPARATOR
Intervention: Individualized race specific warm-up
Number of subjects: 9
Study 18063650 — intervention group
Group type: EXPERIMENTAL
Intervention: Personal feedback (P feedback)
Number of subjects: 588
Study 18063650 — intervention group
Group type: EXPERIMENTAL
Intervention: Personal-normative feedback (PN feedback)
Number of subjects: 588
Study 18063650 — intervention group
Group type: EXPERIMENTAL
Intervention: Personal-normative-action feedback (PNA feedback)
Number of subjects: 588
Study 18063650 — intervention group
Group type: COMPARATOR
Intervention: Generic information
Number of subjects: 588
Study 16567272 — intervention group
Group type: EXPERIMENTAL
Intervention: Mediterranean diet
Number of subjects: 37
Study 16567272 — intervention group
Group type: COMPARATOR
Intervention: Low-fat diet (control)
Number of subjects: 37
Study 14501447 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral corticosteroids (Prednisone 60mg and taper)
Number of subjects: 0
Study 14501447 — intervention group
Group type: COMPARATOR
Intervention: No treatment (control group)
Number of subjects: 0
Study 10892822 — intervention group
Group type: EXPERIMENTAL
Intervention: Telecommunications approach with spiritual and hypertension-related messages via programmed telephone calls
Number of subjects: 83
Study 10892822 — intervention group
Group type: COMPARATOR
Intervention: Control group receiving spiritual messages only
Number of subjects: 83
Study 10892822 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups (experimental and control)
Number of subjects: 83
Study 8616024 — intervention group
Group type: EXPERIMENTAL
Intervention: Melphalan/prednisone
Number of subjects: 581
Study 8616024 — intervention group
Group type: COMPARATOR
Intervention: Melphalan/prednisone + interferon alpha-2b
Number of subjects: 581
Study 1594378 — intervention group
Group type: EXPERIMENTAL
Intervention: Standardized verbal instructions given by housestaff and students trained in their use (verbal group)
Number of subjects: 197
Study 1594378 — intervention group
Group type: EXPERIMENTAL
Intervention: Standardized verbal instructions plus a type-written copy of the information to take home (verbal + written group)
Number of subjects: 197
Study 1594378 — intervention group
Group type: COMPARATOR
Intervention: Instruction by individual housestaff and medical students after consultation with an attending physician (control group)
Number of subjects: 197
Study 3876532 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitrectomy (RAN-S)
Number of subjects: 136
Study 3876532 — intervention group
Group type: COMPARATOR
Intervention: Control (RAN-C)
Number of subjects: 136
Study 3876532 — intervention group
Group type: EXPERIMENTAL
Intervention: Long-term observation (LTO)
Number of subjects: 136
Study 28503770 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous levetiracetam (LEVIV) 20 mg/kg
Number of subjects: 9
Study 28503770 — intervention group
Group type: EXPERIMENTAL
Intervention: Intranasal crushed immediate release levetiracetam (LEVCIR) 30 mg/kg
Number of subjects: 9
Study 28503770 — intervention group
Group type: EXPERIMENTAL
Intervention: Intranasal crushed extended release levetiracetam (LEVCER) 30 mg/kg
Number of subjects: 9
Study 28231815 — intervention group
Group type: EXPERIMENTAL
Intervention: Telerehabilitation programme (videoconferences)
Number of subjects: 0
Study 28231815 — intervention group
Group type: COMPARATOR
Intervention: Traditional physiotherapy intervention
Number of subjects: 0
Study 26246692 — intervention group
Group type: EXPERIMENTAL
Intervention: Standardized fitness training (20 sessions over 8-12 weeks)
Number of subjects: 40
Study 26246692 — intervention group
Group type: COMPARATOR
Intervention: Waitlist control group
Number of subjects: 40
Study 22682875 — intervention group
Group type: EXPERIMENTAL
Intervention: 300 mg CoQ10 + 300 IU vitamin E
Number of subjects: 236
Study 22682875 — intervention group
Group type: COMPARATOR
Intervention: Placebo + 300 IU vitamin E
Number of subjects: 236
Study 21347907 — intervention group
Group type: EXPERIMENTAL
Intervention: Standard behavioral group therapy
Number of subjects: 39
Study 21347907 — intervention group
Group type: COMPARATOR
Intervention: Smoker control group without treatment
Number of subjects: 39
Study 21347907 — intervention group
Group type: COMPARATOR
Intervention: Non-smoker control group
Number of subjects: 39
Study 17311241 — intervention group
Group type: EXPERIMENTAL
Intervention: New treatment for stress urinary incontinence
Number of subjects: 0
Study 16566612 — intervention group
Group type: EXPERIMENTAL
Intervention: Baseline assessments including sociodemographic characteristics and measures of depressive symptom severity
Number of subjects: 1397
Study 16566612 — intervention group
Group type: EXPERIMENTAL
Intervention: Clinical features and sociodemographic characteristics
Number of subjects: 1397
Study 14731163 — intervention group
Group type: EXPERIMENTAL
Intervention: Zidovudine (ZDV) + dideoxycytidine (ddC)
Number of subjects: 0
Study 14731163 — intervention group
Group type: EXPERIMENTAL
Intervention: Zidovudine (ZDV) + didanosine (ddI)
Number of subjects: 0
Study 14731163 — intervention group
Group type: COMPARATOR
Intervention: Zidovudine (ZDV)
Number of subjects: 0
Study 11180310 — intervention group
Group type: COMPARATOR
Intervention: Standard 'Western' ANC model
Number of subjects: 0
Study 11180310 — intervention group
Group type: EXPERIMENTAL
Intervention: 'New' ANC model consisting of tests, clinical procedures and follow‐up actions scientifically demonstrated to be effective in improving maternal and newborn outcomes
Number of subjects: 0
Study 9392500 — intervention group
Group type: EXPERIMENTAL
Intervention: Linoleic acid-enriched, low-cholesterol diet
Number of subjects: 44
Study 7941195 — intervention group
Group type: EXPERIMENTAL
Intervention: 1 mg SIN-1
Number of subjects: 113
Study 7941195 — intervention group
Group type: COMPARATOR
Intervention: P/P (papaverine 15 mg/mL and phentolamine 0.5 mg/mL)
Number of subjects: 113
Study 7941195 — intervention group
Group type: COMPARATOR
Intervention: P/P
Number of subjects: 113
Study 7941195 — intervention group
Group type: EXPERIMENTAL
Intervention: SIN-1
Number of subjects: 113
Study 3048870 — intervention group
Group type: EXPERIMENTAL
Intervention: Lippes Loop
Number of subjects: 395
Study 3048870 — intervention group
Group type: EXPERIMENTAL
Intervention: Multiload-250 and Multiload-375
Number of subjects: 395
Study 3048870 — intervention group
Group type: EXPERIMENTAL
Intervention: TCu 200 and Copper-7
Number of subjects: 395
Study 3048870 — intervention group
Group type: EXPERIMENTAL
Intervention: ProgestasertR
Number of subjects: 395
Study 3048870 — intervention group
Group type: EXPERIMENTAL
Intervention: Serum ferritin
Number of subjects: 395
Study 3048870 — intervention group
Group type: EXPERIMENTAL
Intervention: Haemoglobin (HGB) concentrations
Number of subjects: 395
Study 31790692 — intervention group
Group type: EXPERIMENTAL
Intervention: IPE supplementation with moderate intensity exercise training (EX/IPE group)
Number of subjects: 20
Study 31790692 — intervention group
Group type: COMPARATOR
Intervention: Placebo supplementation with moderate intensity exercise training (EX/Placebo group)
Number of subjects: 20
Study 30454001 — intervention group
Group type: EXPERIMENTAL
Intervention: Preoperative percutaneous catheter drainage (PCD)
Number of subjects: 72
Study 30454001 — intervention group
Group type: COMPARATOR
Intervention: Control group (no PCD)
Number of subjects: 72
Study 26494875 — intervention group
Group type: EXPERIMENTAL
Intervention: Healthy Activity Program (HAP) delivered over 6-8 sessions, focusing on behavioral activation, problem-solving, and social network activation
Number of subjects: 55
Study 26494875 — intervention group
Group type: COMPARATOR
Intervention: Control arm
Number of subjects: 55
Study 25005339 — intervention group
Group type: EXPERIMENTAL
Intervention: Procalcitonin guidance (n=50)
Number of subjects: 110
Study 25005339 — intervention group
Group type: COMPARATOR
Intervention: State-of-the-art guidelines (controls, n=60)
Number of subjects: 110
Study 22917813 — intervention group
Group type: EXPERIMENTAL
Intervention: Enzastaurin (1125 mg on Day 1 followed by 500 mg daily)
Number of subjects: 107
Study 22917813 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 107
Study 22917813 — intervention group
Group type: EXPERIMENTAL
Intervention: Enzastaurin
Number of subjects: 107
Study 20516686 — intervention group
Group type: EXPERIMENTAL
Intervention: 250 ppm F (amine F/NaF) mouthrinse
Number of subjects: 16
Study 20516686 — intervention group
Group type: COMPARATOR
Intervention: Placebo mouthrinse
Number of subjects: 16
Study 18338098 — intervention group
Group type: EXPERIMENTAL
Intervention: 14-mm thick horseshoe-shaped protector
Number of subjects: 15
Study 18338098 — intervention group
Group type: EXPERIMENTAL
Intervention: 16-mm thick continuous protector
Number of subjects: 15
Study 16191912 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-etch adhesive (Adper Prompt)
Number of subjects: 25
Study 16191912 — intervention group
Group type: COMPARATOR
Intervention: Etch & rinse adhesive (Single-Bond)
Number of subjects: 25
Study 12957426 — intervention group
Group type: EXPERIMENTAL
Intervention: Short-term vitamin C administration (3 g intravenous infusion)
Number of subjects: 50
Study 12957426 — intervention group
Group type: EXPERIMENTAL
Intervention: Long-term vitamin C treatment (2 g daily for 3 months)
Number of subjects: 50
Study 12957426 — intervention group
Group type: EXPERIMENTAL
Intervention: Long-term vitamin C treatment (2 g daily for 2 years)
Number of subjects: 50
Study 12957426 — intervention group
Group type: EXPERIMENTAL
Intervention: Short-term vitamin C infusion (3 g intravenous infusion)
Number of subjects: 50
Study 12957426 — intervention group
Group type: EXPERIMENTAL
Intervention: Short-term vitamin C treatment (3 g intravenous infusion)
Number of subjects: 50
Study 12957426 — intervention group
Group type: COMPARATOR
Intervention: Placebo (saline infusion)
Number of subjects: 50
Study 10817181 — intervention group
Group type: EXPERIMENTAL
Intervention: Endoscopic therapy
Number of subjects: 0
Study 10817181 — intervention group
Group type: EXPERIMENTAL
Intervention: Observational studies
Number of subjects: 0
Study 8664039 — intervention group
Group type: EXPERIMENTAL
Intervention: FNA-PCR (polymerase chain reaction)
Number of subjects: 27
Study 8664039 — intervention group
Group type: COMPARATOR
Intervention: Conventional cytopathology
Number of subjects: 27
Study 8664039 — intervention group
Group type: EXPERIMENTAL
Intervention: FNA-PCR
Number of subjects: 27
Study 8664039 — intervention group
Group type: COMPARATOR
Intervention: Controls (disease-free patients)
Number of subjects: 27
Study 1522084 — intervention group
Group type: EXPERIMENTAL
Intervention: Miconazole varnish (single-dose application)
Number of subjects: 50
Study 1522084 — intervention group
Group type: COMPARATOR
Intervention: Miconazole gel (applied three times/day for 15 days)
Number of subjects: 50
Study 6149940 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.25 mg triazolam
Number of subjects: 24
Study 6149940 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.5 mg triazolam
Number of subjects: 24
Study 6149940 — intervention group
Group type: COMPARATOR
Intervention: Placebo (Group A)
Number of subjects: 24
Study 31575375 — intervention group
Group type: EXPERIMENTAL
Intervention: Low energy diet (LED) + Aerobic Interval Training (AIT)
Number of subjects: 70
Study 31575375 — intervention group
Group type: COMPARATOR
Intervention: Aerobic Interval Training (AIT)
Number of subjects: 70
Study 30106266 — intervention group
Group type: EXPERIMENTAL
Intervention: Ifenprodil (60 mg per day for 3 months)
Number of subjects: 68
Study 30106266 — intervention group
Group type: COMPARATOR
Intervention: Control (600 mg ascorbic acid and calcium pantothenate per day for 3 months)
Number of subjects: 68
Study 27001608 — intervention group
Group type: EXPERIMENTAL
Intervention: Complex intervention including practice based workshops, posters, computer prompts, and testing feedback.
Number of subjects: 29
Study 25253123 — intervention group
Group type: EXPERIMENTAL
Intervention: Severe airway obstruction (FEV1/FVC ratio <0.7)
Number of subjects: 3104
Study 25253123 — intervention group
Group type: EXPERIMENTAL
Intervention: Prior use of inhaled steroids
Number of subjects: 3104
Study 25253123 — intervention group
Group type: COMPARATOR
Intervention: Antibiotic therapy
Number of subjects: 3104
Study 22934586 — intervention group
Group type: EXPERIMENTAL
Intervention: Near-peer shadowing program for first-year medical students
Number of subjects: 83
Study 20467288 — intervention group
Group type: EXPERIMENTAL
Intervention: Raltegravir-based therapy
Number of subjects: 273
Study 20467288 — intervention group
Group type: COMPARATOR
Intervention: Ritonavir-boosted protease inhibitor-based therapy
Number of subjects: 273
Study 18638004 — intervention group
Group type: EXPERIMENTAL
Intervention: Mirodenafil 50 mg
Number of subjects: 223
Study 18638004 — intervention group
Group type: EXPERIMENTAL
Intervention: Mirodenafil 100 mg
Number of subjects: 223
Study 18638004 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 223
Study 15838185 — intervention group
Group type: EXPERIMENTAL
Intervention: Paroxetine-Alprazolam Placebo (PAP)
Number of subjects: 22
Study 15838185 — intervention group
Group type: EXPERIMENTAL
Intervention: Paroxetine Placebo-Alprazolam (PPA)
Number of subjects: 22
Study 15838185 — intervention group
Group type: EXPERIMENTAL
Intervention: Paroxetine-Alprazolam (PA)
Number of subjects: 22
Study 15838185 — intervention group
Group type: COMPARATOR
Intervention: Paroxetine Placebo-Alprazolam Placebo (PLA)
Number of subjects: 22
Study 15838185 — intervention group
Group type: EXPERIMENTAL
Intervention: Paroxetine-Alprazolam (PAP)
Number of subjects: 22
Study 12679664 — intervention group
Group type: EXPERIMENTAL
Intervention: rhBMP-2 on an absorbable collagen sponge
Number of subjects: 679
Study 12679664 — intervention group
Group type: COMPARATOR
Intervention: autograft from the iliac crest
Number of subjects: 679
Study 10486418 — intervention group
Group type: EXPERIMENTAL
Intervention: Amiodarone (300 mg intravenous)
Number of subjects: 504
Study 10486418 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 504
Study 8666569 — intervention group
Group type: EXPERIMENTAL
Intervention: Buspirone (15 to 45 mg/day)
Number of subjects: 162
Study 8666569 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 162
Study 1921523 — intervention group
Group type: EXPERIMENTAL
Intervention: Group 1 (usual care + reminder call)
Number of subjects: 2201
Study 1921523 — intervention group
Group type: EXPERIMENTAL
Intervention: Group 2 (usual care + self‐held screening booklet + reminder call)
Number of subjects: 2201
Study 1921523 — intervention group
Group type: EXPERIMENTAL
Intervention: Group 3 (usual care + self‐held screening booklet + instruction call + reminder call)
Number of subjects: 2201
Study 1921523 — intervention group
Group type: COMPARATOR
Intervention: Control Group (advance letter, screening kit, reminder letter)
Number of subjects: 2201
Study 3899666 — intervention group
Group type: EXPERIMENTAL
Intervention: Tamoxifen (TAM) 20 mg/day for 1 yr
Number of subjects: 1005
Study 3899666 — intervention group
Group type: EXPERIMENTAL
Intervention: Tamoxifen (TAM)
Number of subjects: 1005
Study 3899666 — intervention group
Group type: COMPARATOR
Intervention: Control (no further treatment)
Number of subjects: 1005
Study 3899666 — intervention group
Group type: COMPARATOR
Intervention: Ovarian irradiation
Number of subjects: 1005
Study 30887776 — intervention group
Group type: EXPERIMENTAL
Intervention: New method for de-noising ICG signal based on adaptive ensemble empirical mode decomposition and wavelet threshold
Number of subjects: 30
Study 30400372 — intervention group
Group type: EXPERIMENTAL
Intervention: Ancient wheat foodstuffs (made of organic KAMUT® khorasan wheat)
Number of subjects: 63
Study 26524933 — intervention group
Group type: EXPERIMENTAL
Intervention: Epinephrine (0.33 mg/L) added to saline irrigation fluid
Number of subjects: 101
Study 26524933 — intervention group
Group type: COMPARATOR
Intervention: Regular saline irrigation fluid (control group)
Number of subjects: 101
Study 25257804 — intervention group
Group type: EXPERIMENTAL
Intervention: Early specialized palliative care (SPC)
Number of subjects: 300
Study 25257804 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 300
Study 22295814 — intervention group
Group type: EXPERIMENTAL
Intervention: Warming‐promotion acupuncture
Number of subjects: 60
Study 22295814 — intervention group
Group type: COMPARATOR
Intervention: Normal acupuncture
Number of subjects: 60
Study 20205481 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral rehydration therapy (ORT)
Number of subjects: 20
Study 20205481 — intervention group
Group type: EXPERIMENTAL
Intervention: Subcutaneous rehydration therapy (SCRT)
Number of subjects: 20
Study 20205481 — intervention group
Group type: COMPARATOR
Intervention: Intravenous rehydration therapy (IVRT)
Number of subjects: 20
Study 21575243 — intervention group
Group type: EXPERIMENTAL
Intervention: Water aerobics (3 classes per week)
Number of subjects: 66
Study 21575243 — intervention group
Group type: COMPARATOR
Intervention: Routine antenatal care
Number of subjects: 66
Study 16022023 — intervention group
Group type: EXPERIMENTAL
Intervention: Adjunctive local delivery of extracts from Centella asiatica and Punica granatum
Number of subjects: 15
Study 16022023 — intervention group
Group type: COMPARATOR
Intervention: Standard supportive periodontal therapy (SPT)
Number of subjects: 15
Study 12446187 — intervention group
Group type: EXPERIMENTAL
Intervention: Cheese containing Lactobacillus rhamnosus GG and Lactobacillus rhamnosus LC 705, 5 x 15 g per day for 3 weeks
Number of subjects: 74
Study 12446187 — intervention group
Group type: COMPARATOR
Intervention: Control group (placebo)
Number of subjects: 74
Study 12446187 — intervention group
Group type: EXPERIMENTAL
Intervention: Both intervention and control groups
Number of subjects: 74
Study 12446187 — intervention group
Group type: EXPERIMENTAL
Intervention: Probiotic intervention
Number of subjects: 74
Study 9667705 — intervention group
Group type: EXPERIMENTAL
Intervention: Woven grafts
Number of subjects: 267
Study 9667705 — intervention group
Group type: COMPARATOR
Intervention: Knitted collagen-impregnated Dacron grafts
Number of subjects: 267
Study 9667705 — intervention group
Group type: EXPERIMENTAL
Intervention: Both graft types
Number of subjects: 267
Study 9667705 — intervention group
Group type: EXPERIMENTAL
Intervention: Knitted grafts
Number of subjects: 267
Study 8076229 — intervention group
Group type: EXPERIMENTAL
Intervention: Midazolam (0.07 mg.kg‐1 for <65 years, 0.06 mg.kg‐1 for ≥65 years)
Number of subjects: 100
Study 8076229 — intervention group
Group type: COMPARATOR
Intervention: Diazepam (0.15 mg.kg‐1 for <65 years, 0.11 mg.kg‐1 for ≥65 years)
Number of subjects: 100
Study 2531570 — intervention group
Group type: EXPERIMENTAL
Intervention: Calcipotriol 25 micrograms/g
Number of subjects: 50
Study 2531570 — intervention group
Group type: EXPERIMENTAL
Intervention: Calcipotriol 50 micrograms/g
Number of subjects: 50
Study 2531570 — intervention group
Group type: EXPERIMENTAL
Intervention: Calcipotriol 100 micrograms/g
Number of subjects: 50
Study 2531570 — intervention group
Group type: COMPARATOR
Intervention: Placebo (vehicle alone)
Number of subjects: 50
Study 2531570 — intervention group
Group type: EXPERIMENTAL
Intervention: Overall treatment with calcipotriol ointment
Number of subjects: 50
Study 30325703 — intervention group
Group type: EXPERIMENTAL
Intervention: SAC program (high stress shooting with real persons)
Number of subjects: 98
Study 30325703 — intervention group
Group type: COMPARATOR
Intervention: Dummy men training (low stress)
Number of subjects: 98
Study 28846532 — intervention group
Group type: EXPERIMENTAL
Intervention: Rigid fixation using sternal plates (Group R)
Number of subjects: 80
Study 28846532 — intervention group
Group type: COMPARATOR
Intervention: Sternal wire fixation (Group C)
Number of subjects: 80